Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Patient-Reported Treatment Experience with Oral Rivaroxaban: Results from the Noninterventional XALIA Study of Deep-Vein Thrombosis.
TH Open. 2018 Apr 11;2(2):e139-e146. doi: 10.1055/s-0038-1641679. eCollection 2018 Apr.
TH Open. 2018.
PMID: 31249937
Free PMC article.
Left atrial thrombus resolution in non-valvular atrial fibrillation or flutter: biomarker substudy results from a prospective study with rivaroxaban (X-TRA).
Miyazawa K, Pastori D, Hammerstingl C, Cappato R, Meng IL, Kramer F, Cohen A, Schulz A, Eickels MV, Lip GYH, Marin F.
Miyazawa K, et al. Among authors: eickels mv.
Ann Med. 2018 Sep;50(6):511-518. doi: 10.1080/07853890.2018.1495337.
Ann Med. 2018.
PMID: 29956554
Clinical Trial.
Item in Clipboard
The soluble guanylate cyclase activator HMR1766 reverses hypoxia-induced experimental pulmonary hypertension in mice.
Weissmann N, Hackemack S, Dahal BK, Pullamsetti SS, Savai R, Mittal M, Fuchs B, Medebach T, Dumitrascu R, Eickels Mv, Ghofrani HA, Seeger W, Grimminger F, Schermuly RT.
Weissmann N, et al. Among authors: eickels mv.
Am J Physiol Lung Cell Mol Physiol. 2009 Oct;297(4):L658-65. doi: 10.1152/ajplung.00189.2009. Epub 2009 Jul 17.
Am J Physiol Lung Cell Mol Physiol. 2009.
PMID: 19617308
Free article.
Item in Clipboard
Cite
Cite